Referencing Approved Drug Products in ANDA Submissions (9of28) Generic Drugs Forum – Apr. 3-4, 2019
Referencing Approved Drug Products in ANDA Submissions
10 Facts about What FDA Does and Does Not Approve #FDAFacts (1-10)
Filing Review Basics – Examples of Refuse-to-Receive (RTR) (15of27) Generic Drugs Forum 2018
Generic Drug Labeling: Recommendations for High-Quality Submissions (4of28) Generic Drugs Forum 2020
Orange Book: An Overview of Therapeutic Equivalence
Overview of the FDA Product-Specific Guidance Program
Improving the Sterility Assurance Application to the FDA – Generic Drugs Forum (GDF) 2024
Common Labeling Deficiencies and Tips for Generic Drug Applications
ANDA Program Performance Review and Tips (8of16) Generic Drugs Forum 2020
Generic Labeling: Strategies for Providing High-quality Submissions (18/28) Generic Drugs Forum 2017
Not All Drugs Get Approved the Same Way: Exceptions to FDA Rules
Navigating FDA's Drug Information Resources
Introduction to “The ANDA Review Pathway” (11/28) Generic Drugs Forum 2017
Review of Clinical Endpoint Bioequivalence Studies in ANDAs (17/28) Generic Drugs Forum 2017
FDA’s Bioequivalence Recommendations for Generic Drugs (16/28) Generic Drugs Forum 2017
Therapeutic Equivalence - PTCB PTCE NAPLEX NCLEX Test Prep CPhT Pharmacy Tech PTCE Content Outline
Generic Drug Product Quality Assessment (22of27) Generic Drugs Forum 2018
Division of Filing Review: Helpful Tips for Submission of an ANDA or Controlled Correspondence
A dose of reality about generic drugs